MedTrace Logo

The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia

NCT04143308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-06-21

No results posted yet for this study

Summary

The object is to develop a training system of simultaneous walking and cognitive training for improving cognitive function of people with schizophrenia. The training program, called "Simultaneous Walk And Think for Cognitive Health mobile application software"(SWATCH App), is developed by researchers. A randomized controlled trial will be carried out to test the effectiveness of the training system. Ninety participants will be randomly assigned to: simultaneous training of walking and cognitive group, the cognitive training group, and treatment as usual group. The intervention for those groups will lasts for 12 weeks, with a 12 week of followup. The measurements include the cognitive function, physical fitness, and quality of life.

Conditions

  • Schizophrenia
  • Cognitive Function
  • Physical Activity
  • Quality of Life

Interventions

OTHER

Simultaneous training of walking and cognitive group

Device: 1. SWATCH system (App \& controller) 2. Wearable technology Fitness wristband \& APP

OTHER

Cognitive training group

Device: 1. SWATCH system (App) 2. Wearable technology Fitness wristband \& APP

OTHER

Treatment as usual group

Keep treatment as usual

Sponsors & Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Principal Investigators

  • Ming-De Chen, Ph.D. · Department of Occupational Therapy, College of Health Sciences, Kaohsiung Medical University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-05
Primary Completion
2021-07-07
Completion
2021-07-07

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04143308 on ClinicalTrials.gov